REAL-WORLD USE OF SELEXIPAG AND OTHER PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPIES: AN OBSERVATIONAL COHORT STUDY IN PATIENTS WITH PAH (EXPOSURE)

被引：0
|
作者：
Muller, A. [1 ]
Soderberg, S. [2 ]
Escribano, P. [3 ]
Biedermann, P. [1 ]
Sun, H. [1 ]
Lange, T. J. [4 ]
Gaine, S. [5 ]
机构：
[1] Actelion Pharmaceut Ltd, Allschwil, Switzerland
[2] Umea Univ, Cardiol & Heart Ctr, Dept Publ Hlth & Clin Med, Umea, Sweden
[3] Hosp Univ 12 Octubre, Madrid, Spain
[4] Univ Med Ctr Regensburg, Regensburg, Germany
[5] Mater Misericordiae Univ Hosp, Dublin, Ireland
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDG37
引用
收藏
页码：S602 / S603
页数：2
相关论文
共 50 条
  • [1] Selexipag real-world experience in patients over 75 yrs with pulmonary arterial hypertension (PAH)
    Gaine, Sean
    Escribano, Pilar
    Biedermann, Patricia
    Muller, Audrey
    Sun, Hong
    Soderberg, Stefan
    Lange, Tobias J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [2] Selexipag Titration and Dosing Patterns in Patients with Pulmonary Arterial Hypertension (PAH) in a Real-World Clinical Setting: Insights from the EXPOSURE Study
    Lange, T. J.
    Soderberg, S.
    Biedermann, P.
    Muller, A.
    Luik, K.
    Escribano, P.
    Gaine, S. P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [3] SELEXIPAG TITRATION AND DOSING PATTERNS IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN A REAL-WORLD CLINICAL SETTING: INSIGHTS FROM THE EXPOSURE STUDY
    Johnson, M. K.
    Lange, T. J.
    Soederberg, S.
    Biedermann, P.
    Muller, A.
    Luik, K.
    Escribano, P.
    Gaine, S.
    [J]. THORAX, 2021, 76 : A50 - A51
  • [4] Clinical Characteristics and Treatment Patterns in Patients with Pulmonary Arterial Hypertension (PAH) Initiating Selexipag in the EXPOSURE Observational Study
    Lange, T. J.
    Escribano, P.
    Biedermann, P.
    Muller, A.
    Sun, H.
    Soderberg, S.
    Gaine, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] Clinical Characteristics and Treatment Patterns in Patients with Pulmonary Arterial Hypertension (PAH) Initiating Selexipag in the EXPOSURE Observational Study
    Lange, T. J.
    Escribano, P.
    Biedermann, P.
    Muller, A.
    Sun, H.
    Soderberg, S.
    Gaine, S.
    [J]. PNEUMOLOGIE, 2021, 75 : S22 - S22
  • [6] Real-world Use of Upfront Combination Therapy in Pulmonary Arterial Hypertension (PAH) Patients
    Paoli, C.
    Tang, W.
    Panjabi, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [7] Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD): Real-world experience from EXPOSURE
    Gaine, Sean
    Escribano-Subias, Pilar
    Muller, Audrey
    Fernandes, Catarina C.
    Fontana, Martina
    Remenova, Tatiana
    Soderberg, Stefan
    Lange, Tobias J.
    [J]. PULMONARY CIRCULATION, 2024, 14 (03)
  • [8] Selexipag Experience in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (PAH-CTD): Real-World Experience from EXPOSURE
    Gaine, S. P.
    Escribano, P.
    Muller, A.
    Klement, R.
    Soderberg, S.
    Lange, T. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [9] Four-strata risk assessment in pulmonary arterial hypertension (PAH) patients treated with selexipag in real-world settings: Insights from EXPOSURE
    Lange, Tobias
    Escribano, Pilar
    Muller, Audrey
    Fontana, Martina
    Soderberg, Stefan
    Gaine, Sean
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] CARE PAH study design: an international, prospective real-world cohort of PAH patients
    Humbert, M.
    Dreyer, N.
    Mclaughlin, V
    Pulido, T.
    Boyanova, N.
    Frauchiger, B.
    Kiefer, F.
    Lassen, C.
    Ong, R.
    Sanna, L.
    Sauter, A.
    Kiely, D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
12345